Lab Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Response Biomedical

Recent reports from Response Biomedical provided an update

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Response Biomedical.

Report 1: Response Biomedical Corporation (RBM) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the patent titled "Sensitive Immunochromatographic Assay."

This patent covers key aspects of Response Biomedical's lateral flow immunoassays with the RAMP point-of-care testing platform. The RAMP platform provides highly sensitive and reliable results, typically in less than 15 minutes.

...

• View Other Issues of Lab Business Week
  
• View Other NewsRx Publications